home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  February 25, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 473 active entries

PX'Therapeutics SAS

7 Parvis Louis Néel - MINATEC BHT 52A
38040 Grenoble cedex 9

Phone: +33 (0)438 023 650
Fax: +33 (0)476 961 038

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Located in Grenoble (France), PX’Therapeutics provides integrated biologics development and manufacturing contract services. Organized around technology platforms, PX’Therapeutics offers custom programs which may include, depending on clients' needs:
- murine antibody generation and development of chimeric, humanized and fully human mAbs
- mg to 100 g scale protein and mAb production
- expression systems: bacteria, insect cells, yeasts, mammalian cells
- R&D grade or GMP grade cell line development (CHO-PX or other cells)
- Process development
- small-mid scale GMP manufacturing
- regulatory expertise

PX’Therapeutics has been extensively involved in the discovery, development and manufacturing of drug targets, vaccines, cell-based products, therapeutic proteins and monoclonal antibodies with over 800 projects performed over the past 13 years through 200 customers (North America, Europe, Asia).

Selected Categories:
Product Company   Service Company
- Research
- Services

Last update of this entry: November 05, 2013

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.